Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts

Fig. 3

Efficacy of i.p. CpG-ODN1826 (20 µg/mouse, qdx5d/wx4w) against orthotopic DMPM STO xenografts. a Orthotopic STO tumor weight distribution. Mice (six animals/group) were randomized to receive saline or CpG-ODN1826. The treatment started 4 days after cell injection (early-stage tumors). b Mice (ten animals/group) were randomized to receive saline or CpG-ODN1826. The treatment started 11 days after cell injection (late-stage tumors)

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us